APA (7th ed.) Citation

S, E., Y, H., IN, U., M, H., H, U., A, V., . . . A, E. (2026). IDH1 Mutant Glioma Favors Group 3 Innate Lymphoid Cells and Is Resistant to Immune Checkpoint Expression. Inflammation research : official journal of the European Histamine Research Society ... [et al.], 75(1), . https://doi.org/10.1007/s00011-026-02223-8

Chicago Style (17th ed.) Citation

S, Erdem, Haliloglu Y, Uslu IN, Houran M, Ulutabanca H, Vural A, Erturhan MB, Canatan H, and Eken A. "IDH1 Mutant Glioma Favors Group 3 Innate Lymphoid Cells and Is Resistant to Immune Checkpoint Expression." Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.] 75, no. 1 (2026). https://doi.org/10.1007/s00011-026-02223-8.

MLA (9th ed.) Citation

S, Erdem, et al. "IDH1 Mutant Glioma Favors Group 3 Innate Lymphoid Cells and Is Resistant to Immune Checkpoint Expression." Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.], vol. 75, no. 1, 2026, https://doi.org/10.1007/s00011-026-02223-8.